121 related articles for article (PubMed ID: 26235178)
21. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
Monti SM; Supuran CT; De Simone G
Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase IX/G250/MN: a molecule too good to be true?
Oosterwijk E
BJU Int; 2008 Mar; 101(5):527-8. PubMed ID: 18257853
[No Abstract] [Full Text] [Related]
23. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
[TBL] [Abstract][Full Text] [Related]
24. Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells.
Radvak P; Repic M; Svastova E; Takacova M; Csaderova L; Strnad H; Pastorek J; Pastorekova S; Kopacek J
Oncol Rep; 2013 Mar; 29(3):1147-53. PubMed ID: 23291973
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
26. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
Knaus EE; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
[TBL] [Abstract][Full Text] [Related]
27. In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives.
Ahlskog JK; Dumelin CE; Trüssel S; Mårlind J; Neri D
Bioorg Med Chem Lett; 2009 Aug; 19(16):4851-6. PubMed ID: 19615903
[TBL] [Abstract][Full Text] [Related]
28. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S
Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
[TBL] [Abstract][Full Text] [Related]
29. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
Grandane A; Tanc M; Zalubovskis R; Supuran CT
Bioorg Med Chem Lett; 2014 Mar; 24(5):1256-60. PubMed ID: 24518190
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
D'Ambrosio K; Vitale RM; Dogné JM; Masereel B; Innocenti A; Scozzafava A; De Simone G; Supuran CT
J Med Chem; 2008 Jun; 51(11):3230-7. PubMed ID: 18481843
[TBL] [Abstract][Full Text] [Related]
31. Novel sulfonamide compounds for inhibition of metastatic tumor growth (WO2012021963).
Colinas PA
Expert Opin Ther Pat; 2013; 23(6):761-3. PubMed ID: 23566197
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
Signoretti S; Regan M; Atkins M
BJU Int; 2008 Jun; 101 Suppl 4():31-5. PubMed ID: 18430120
[No Abstract] [Full Text] [Related]
33. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
Potter CP; Harris AL
Br J Cancer; 2003 Jul; 89(1):2-7. PubMed ID: 12838292
[TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT
Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111
[TBL] [Abstract][Full Text] [Related]
36. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
[TBL] [Abstract][Full Text] [Related]
38. In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
Brouwers AH; Boerman OC; Oyen WJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8886; author reply 8886. PubMed ID: 16361579
[No Abstract] [Full Text] [Related]
39. Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.
Shuch B; Li Z; Belldegrun AS
BJU Int; 2008 Jun; 101 Suppl 4():25-30. PubMed ID: 18430119
[No Abstract] [Full Text] [Related]
40. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer.
Winum JY; Colinas PA; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1419-26. PubMed ID: 23199483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]